Gemwem Injection
Marketer
Wembrace Biopharma Pvt. Ltd.
Salt Composition
Gemcitabine (200mg)
Overview Gemwem Injection
Gemwem Injection treats several cancers, including non-small cell lung, breast, pancreatic, bladder, and ovarian cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your doctor based on your condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdosage can lead to severe adverse effects. While benefits may take weeks or months to appear, discontinue use only under your doctor's guidance. Common side effects include nausea, vomiting, appetite loss, alopecia, and thrombocytopenia. The medication can decrease blood cell counts, increasing infection risk. Regular blood tests monitoring blood cell levels, along with heart, liver, and uric acid levels, are necessary. Inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent use of infection-fighting medications before commencing treatment. Interactions with other medications are possible; disclose all medications to your physician. Gemwem Injection is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is crucial during treatment.
Uses of Gemwem Injection
Lung cancer (non-small cell type), breast cancer, pancreatic cancer, bladder cancer, and ovarian cancer.
Major Benefits of Gemwem Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Gemwem Injection:
- Nausea
- Vomiting
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Breathlessness
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use Gemwem Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Gemwem Injection works:
Gemwem Injection disrupts cancer cell proliferation by replacing essential DNA and RNA components, thus halting their growth and replication.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Gemwem Injection and alcohol may result in pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
Administering Gemwem Injection during pregnancy is contraindicated due to established risk to the fetus. In exceptional life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Gemwem Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Administering Gemwem Injection might reduce vigilance, impair visual acuity, or induce drowsiness and dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Gemwem Injection's use in individuals with renal impairment. Physician consultation is recommended. Pre-treatment and ongoing assessment of kidney function are advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Gemwem Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Gemwem Injection :
NA
Facts to Know About Gemwem Injection
| Label | Value |
|---|---|
| Chemical Category | Modified Cytosine |
| Developing Good Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Metabolic Inhibitors |
3,018 People bought this recently